Archive for the ‘authorship issues’ Category
The reasons for the retractions range from expired kits, an “unattributed overlap” with another paper, “authorship issues,” and issues over sample sizes.
Tomader Taha Abdel Rahman, a researcher at Ain Shams University in Cairo, is the first author on two of the papers, and second author on the third.
Here’s the retraction note for a paper that showed elderly adults with chronic hepatitis C are at risk of having cognitive issues:
The Cochrane Library has withdrawn two reviews evaluating the effectiveness of diabetes treatments because some of the papers’ authors work with pharmaceutical companies.
Bianca Hemmingsen, first author on both reviews, told us the Cochrane Library asked the authors to remove the researchers with ties to pharma, but after one “refused to withdraw,” both papers were pulled entirely.
However, Hemmingsen insists that their employment had no impact on either paper.
This breaks the typical mold for Cochrane withdrawals, which are usually only pulled to indicate updates and show that older reviews no longer represent the best evidence.
On Monday, we reported on 64 new retractions from Springer journals resulting from fake peer reviews. Yesterday, SAGE — which retracted 60 papers for the same reason just over a year ago — added 17 additional retractions to their list.
The articles were published in five different journals, and one retraction involved authorship fraud in addition to peer review fraud, according to a SAGE spokesperson: Read the rest of this entry »
The retraction note for “Preparation and dielectric properties of BaTiO3:epoxy nanocomposites for embedded capacitor application” is short and sweet. Here it is, in full:
The Veterinary Journal has retracted a 2014 paper that found that sheep eat more when their food is supplemented with urea (yes, the same compound found in urine).
The notice was published after a “complaint which raised serious concerns.”
Here’s more from the notice:
The properties of pine needles in northwestern China differ — both inside and out — depending on where on the slope of a mountain they are situated. The properties of a recent paper on this phenomenon have recently changed from “published” to “retracted.”
It appears that some of the authors didn’t realize it had been submitted to The Scientific World Journal. The paper has not been cited, according to Thomson Scientific’s Web of Knowledge.
Eurosurveillance is investigating potential problems with study on the deadly breakout of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea. The notice was issued after the journal discovered that study data might have been used without permission.
“Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015,” was published last month by a group of researchers at the Gyeonggi Infectious Disease Control Center in Korea, and details 37 cases of people at one hospital, one portion of the nearly 200 who’ve developed the new respiratory infection since the outbreak began. The researchers tracked the path of infection from one initial patient to 25 secondary cases, who then infected 11 additional people. As the researchers note:
Yup, this happened: “Mystery” writer impersonated cardiovascular pathologist, penned published letter
A 2014 letter in the Journal of the American College of Cardiology has been retracted because editors aren’t sure who wrote it.
“Can Grayscale IVUS Detect Necrotic Core-Rich Plaque?”, a letter on the potential of intravascular ultrasound, was submitted under the name of a researcher at the University of Copenhagen, Erling Falk. The paper was sent with a Gmail account (a technique used by some academics to conduct fake peer reviews), and editors communicated with the author through the acceptance process.
Shortly after the letter was published, Erling Falk of Aarhus University contacted the journal and asked who wrote the letter. They discovered that nobody by that name worked at the University of Copenhagen and emails to the author’s Gmail address went unanswered. So the journal issued a retraction.
Here’s the complete notice:
An economist in Taiwan has retracted a paper about from Economic Development Quarterly because it was “published in error.”
The paper — first published online March 5, 2013 — addresses the influence of information and communication technology on economic growth.
According to the notice, the paper included “the original dataset and excerpts from an earlier draft of the paper co-written by the author and colleagues.” The only listed author, Yi-Chia Wang, asked that the article be retracted before making it into print, but it looks like it was included in the February, 2015 issue of the journal.
The paper, “N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation,” was ostensibly written by nine researchers at the Collaborative Innovation Center for Marine Biomass Fiber, Materials and Textiles of Shandong Province, the Shandong Sino-Japanese Center for Collaborative Research of Carbon Nanomaterials, Laboratory of Fiber Materials and Modern Textiles, the Growing Base for State Key Laboratory at the College of Chemical Science and Engineering at Qingdao University, and Mayo Clinic, in Rochester, Minn.